TEHRAN – Concerning the importance of integrating new applied sciences into the healthcare system, a trilateral memorandum of understanding (MOU) has been signed to promote the nation’s standing within the plasma medicine trade.
The MOU was signed by Saeed Sarkar, an official with the Vice-Presidency for Science and Technology, Shahin Akhoundzadeh, an official with the Ministry of Health, and Mahdiyeh Bakhtiari, the CEO of the Plasma Therapy Knowledge-Based Company, IRNA reported.
The most important targets of the MOU are to develop and implement in depth multi-center analysis in plasma medicine, combine the know-how within the nation’s official therapy protocols, in addition to conduct initiatives that play an efficient position in treating hard-to-cure ailments, enhance well being providers, and supply entry to superior medical applied sciences.
The MOU represents the collaboration of the scientific, analysis, and technological capabilities of the nation, a nationwide motion in direction of the enlargement of rising applied sciences within the area of medicine.
First indigenous plasma remedy clinic
In April, the Atomic Energy Organization of Iran (AEOI), in cooperation with Jahrom University of Medical Sciences, southern Fars province, launched the primary chilly plasma remedy clinic for the therapy of wounds utilizing indigenous know-how.
During the opening ceremony, the AEOI head, Mohammad Eslami, related the achievement with scientific progress and nationwide self-confidence, highlighting that nuclear know-how is utilized in medical providers and agriculture.
The inauguration of this clinic can assist increase plasma remedy know-how in different medical facilities within the nation, the official famous.
The chancellor of Jahrom University of Medical Sciences, Hossein Hakimelahi, for his half, expressed hope that this initiative will open up alternatives to use nuclear applied sciences in most cancers therapy and different areas of well being.
On August 26, Eslami stated heavy water derivatives and plasma medicine are opening new frontiers in drug growth and medical therapy, marking a serious step within the software of nuclear know-how to public well being.
Eslami added that underneath a memorandum of understanding with the Ministry of Health, scientific trials that had been beforehand concentrated at Tehran University might be expanded to chosen universities throughout the nation.
“This will accelerate the spread of plasma-based technologies to different provinces,” he stated, “ensuring that all Iranians can benefit equally and simultaneously from these advances.”
The remarks got here throughout ceremonies marking National Doctors Day, the place Eslami additionally highlighted the AEOI’s success in producing greater than 70 varieties of radiopharmaceuticals, now equipped to over 220 nuclear medicine facilities throughout Iran and exported overseas.
These merchandise, Eslami stated, cowl three classes: diagnostic, therapeutic, and palliative.
In the diagnostic area, advances are pushing “the frontiers of knowledge,” bettering precision so medical doctors can higher study sufferers’ our bodies. On the therapeutic facet, he added, the main target is on easing sufferers’ struggling whereas offering more practical remedies.
Eslami revealed that round 20 further radiopharmaceuticals are presently underneath analysis and in scientific trial phases, reflecting Iran’s rising capability to combine nuclear science into healthcare.
MT/MG